{
  "id": "https://openalex.org/W2405151655",
  "doi": null,
  "title": "Can rash associated with HER1/EGFR inhibition be used as a marker of treatment outcome?",
  "display_name": "Can rash associated with HER1/EGFR inhibition be used as a marker of treatment outcome?",
  "publication_year": 2003,
  "publication_date": "2003-11-01",
  "ids": {
    "openalex": "https://openalex.org/W2405151655",
    "mag": "2405151655",
    "pmid": "https://pubmed.ncbi.nlm.nih.gov/14682120"
  },
  "language": "en",
  "primary_location": {
    "is_oa": false,
    "landing_page_url": "https://pubmed.ncbi.nlm.nih.gov/14682120",
    "pdf_url": null,
    "source": {
      "id": "https://openalex.org/S4306525036",
      "display_name": "PubMed",
      "issn_l": null,
      "issn": null,
      "is_oa": false,
      "is_in_doaj": false,
      "is_indexed_in_scopus": false,
      "is_core": false,
      "host_organization": "https://openalex.org/I1299303238",
      "host_organization_name": "National Institutes of Health",
      "host_organization_lineage": [
        "https://openalex.org/I1299303238"
      ],
      "host_organization_lineage_names": [
        "National Institutes of Health"
      ],
      "type": "repository"
    },
    "license": null,
    "license_id": null,
    "version": null,
    "is_accepted": false,
    "is_published": false
  },
  "type": "article",
  "type_crossref": "journal-article",
  "indexed_in": [
    "pubmed"
  ],
  "open_access": {
    "is_oa": false,
    "oa_status": "closed",
    "oa_url": null,
    "any_repository_has_fulltext": false
  },
  "authorships": [
    {
      "author_position": "first",
      "author": {
        "id": "https://openalex.org/A5110045421",
        "display_name": "Román Pérez-Soler",
        "orcid": null
      },
      "institutions": [
        {
          "id": "https://openalex.org/I1335289525",
          "display_name": "Montefiore Medical Center",
          "ror": "https://ror.org/044ntvm43",
          "country_code": "US",
          "type": "healthcare",
          "lineage": [
            "https://openalex.org/I1335289525"
          ]
        },
        {
          "id": "https://openalex.org/I129975664",
          "display_name": "Albert Einstein College of Medicine",
          "ror": "https://ror.org/05cf8a891",
          "country_code": "US",
          "type": "education",
          "lineage": [
            "https://openalex.org/I129975664",
            "https://openalex.org/I4210112371"
          ]
        }
      ],
      "countries": [
        "US"
      ],
      "is_corresponding": true,
      "raw_author_name": "Romàn Pérez-Soler",
      "raw_affiliation_strings": [
        "Department of Oncology, Montefiore Medical Center, Division of Medical Oncology, Albert Einstein College of Medicine, New York, New York, USA."
      ],
      "affiliations": [
        {
          "raw_affiliation_string": "Department of Oncology, Montefiore Medical Center, Division of Medical Oncology, Albert Einstein College of Medicine, New York, New York, USA.",
          "institution_ids": [
            "https://openalex.org/I1335289525",
            "https://openalex.org/I129975664"
          ]
        }
      ]
    }
  ],
  "institution_assertions": [],
  "countries_distinct_count": 1,
  "institutions_distinct_count": 2,
  "corresponding_author_ids": [
    "https://openalex.org/A5110045421"
  ],
  "corresponding_institution_ids": [
    "https://openalex.org/I1335289525",
    "https://openalex.org/I129975664"
  ],
  "apc_list": null,
  "apc_paid": null,
  "fwci": 13.072,
  "has_fulltext": false,
  "cited_by_count": 150,
  "citation_normalized_percentile": {
    "value": 0.91108,
    "is_in_top_1_percent": false,
    "is_in_top_10_percent": true
  },
  "cited_by_percentile_year": {
    "min": 97,
    "max": 98
  },
  "biblio": {
    "volume": "17",
    "issue": "11 Suppl 12",
    "first_page": "23",
    "last_page": "8"
  },
  "is_retracted": false,
  "is_paratext": false,
  "primary_topic": {
    "id": "https://openalex.org/T10417",
    "display_name": "Lung Cancer Treatments and Mutations",
    "score": 0.9997,
    "subfield": {
      "id": "https://openalex.org/subfields/2740",
      "display_name": "Pulmonary and Respiratory Medicine"
    },
    "field": {
      "id": "https://openalex.org/fields/27",
      "display_name": "Medicine"
    },
    "domain": {
      "id": "https://openalex.org/domains/4",
      "display_name": "Health Sciences"
    }
  },
  "topics": [
    {
      "id": "https://openalex.org/T10417",
      "display_name": "Lung Cancer Treatments and Mutations",
      "score": 0.9997,
      "subfield": {
        "id": "https://openalex.org/subfields/2740",
        "display_name": "Pulmonary and Respiratory Medicine"
      },
      "field": {
        "id": "https://openalex.org/fields/27",
        "display_name": "Medicine"
      },
      "domain": {
        "id": "https://openalex.org/domains/4",
        "display_name": "Health Sciences"
      }
    },
    {
      "id": "https://openalex.org/T10755",
      "display_name": "HER2/EGFR in Cancer Research",
      "score": 0.999,
      "subfield": {
        "id": "https://openalex.org/subfields/2730",
        "display_name": "Oncology"
      },
      "field": {
        "id": "https://openalex.org/fields/27",
        "display_name": "Medicine"
      },
      "domain": {
        "id": "https://openalex.org/domains/4",
        "display_name": "Health Sciences"
      }
    },
    {
      "id": "https://openalex.org/T12505",
      "display_name": "Peptidase Inhibition and Analysis",
      "score": 0.9985,
      "subfield": {
        "id": "https://openalex.org/subfields/2730",
        "display_name": "Oncology"
      },
      "field": {
        "id": "https://openalex.org/fields/27",
        "display_name": "Medicine"
      },
      "domain": {
        "id": "https://openalex.org/domains/4",
        "display_name": "Health Sciences"
      }
    }
  ],
  "keywords": [
    {
      "id": "https://openalex.org/keywords/erlotinib-hydrochloride",
      "display_name": "Erlotinib Hydrochloride",
      "score": 0.45588717
    }
  ],
  "concepts": [
    {
      "id": "https://openalex.org/C2778570526",
      "wikidata": "https://www.wikidata.org/wiki/Q653197",
      "display_name": "Rash",
      "level": 2,
      "score": 0.9435843
    },
    {
      "id": "https://openalex.org/C2778087573",
      "wikidata": "https://www.wikidata.org/wiki/Q418369",
      "display_name": "Erlotinib",
      "level": 4,
      "score": 0.9336511
    },
    {
      "id": "https://openalex.org/C71924100",
      "wikidata": "https://www.wikidata.org/wiki/Q11190",
      "display_name": "Medicine",
      "level": 0,
      "score": 0.83207345
    },
    {
      "id": "https://openalex.org/C2780580887",
      "wikidata": "https://www.wikidata.org/wiki/Q417824",
      "display_name": "Gefitinib",
      "level": 4,
      "score": 0.7915385
    },
    {
      "id": "https://openalex.org/C2779998722",
      "wikidata": "https://www.wikidata.org/wiki/Q420296",
      "display_name": "Cetuximab",
      "level": 4,
      "score": 0.73571414
    },
    {
      "id": "https://openalex.org/C2776256026",
      "wikidata": "https://www.wikidata.org/wiki/Q47912",
      "display_name": "Lung cancer",
      "level": 2,
      "score": 0.64219034
    },
    {
      "id": "https://openalex.org/C126322002",
      "wikidata": "https://www.wikidata.org/wiki/Q11180",
      "display_name": "Internal medicine",
      "level": 1,
      "score": 0.62602216
    },
    {
      "id": "https://openalex.org/C143998085",
      "wikidata": "https://www.wikidata.org/wiki/Q162555",
      "display_name": "Oncology",
      "level": 1,
      "score": 0.54272103
    },
    {
      "id": "https://openalex.org/C2779438470",
      "wikidata": "https://www.wikidata.org/wiki/Q424401",
      "display_name": "Epidermal growth factor receptor",
      "level": 3,
      "score": 0.5269628
    },
    {
      "id": "https://openalex.org/C2909325608",
      "wikidata": "https://www.wikidata.org/wiki/Q418369",
      "display_name": "Erlotinib Hydrochloride",
      "level": 5,
      "score": 0.45588717
    },
    {
      "id": "https://openalex.org/C121608353",
      "wikidata": "https://www.wikidata.org/wiki/Q12078",
      "display_name": "Cancer",
      "level": 2,
      "score": 0.36115703
    },
    {
      "id": "https://openalex.org/C526805850",
      "wikidata": "https://www.wikidata.org/wiki/Q188874",
      "display_name": "Colorectal cancer",
      "level": 3,
      "score": 0.076291084
    }
  ],
  "mesh": [
    {
      "descriptor_ui": "D002289",
      "descriptor_name": "Carcinoma, Non-Small-Cell Lung",
      "qualifier_ui": "Q000188",
      "qualifier_name": "drug therapy",
      "is_major_topic": true
    },
    {
      "descriptor_ui": "D066246",
      "descriptor_name": "ErbB Receptors",
      "qualifier_ui": "Q000037",
      "qualifier_name": "antagonists & inhibitors",
      "is_major_topic": true
    },
    {
      "descriptor_ui": "D005076",
      "descriptor_name": "Exanthema",
      "qualifier_ui": "Q000139",
      "qualifier_name": "chemically induced",
      "is_major_topic": true
    },
    {
      "descriptor_ui": "D005076",
      "descriptor_name": "Exanthema",
      "qualifier_ui": "Q000145",
      "qualifier_name": "classification",
      "is_major_topic": true
    },
    {
      "descriptor_ui": "D006258",
      "descriptor_name": "Head and Neck Neoplasms",
      "qualifier_ui": "Q000188",
      "qualifier_name": "drug therapy",
      "is_major_topic": true
    },
    {
      "descriptor_ui": "D008175",
      "descriptor_name": "Lung Neoplasms",
      "qualifier_ui": "Q000188",
      "qualifier_name": "drug therapy",
      "is_major_topic": true
    },
    {
      "descriptor_ui": "D010051",
      "descriptor_name": "Ovarian Neoplasms",
      "qualifier_ui": "Q000188",
      "qualifier_name": "drug therapy",
      "is_major_topic": true
    },
    {
      "descriptor_ui": "D011799",
      "descriptor_name": "Quinazolines",
      "qualifier_ui": "Q000009",
      "qualifier_name": "adverse effects",
      "is_major_topic": true
    },
    {
      "descriptor_ui": "D000911",
      "descriptor_name": "Antibodies, Monoclonal",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D000911",
      "descriptor_name": "Antibodies, Monoclonal",
      "qualifier_ui": "Q000009",
      "qualifier_name": "adverse effects",
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D000911",
      "descriptor_name": "Antibodies, Monoclonal",
      "qualifier_ui": "Q000627",
      "qualifier_name": "therapeutic use",
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D061067",
      "descriptor_name": "Antibodies, Monoclonal, Humanized",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D015415",
      "descriptor_name": "Biomarkers",
      "qualifier_ui": "Q000032",
      "qualifier_name": "analysis",
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D015415",
      "descriptor_name": "Biomarkers",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D002289",
      "descriptor_name": "Carcinoma, Non-Small-Cell Lung",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D000068818",
      "descriptor_name": "Cetuximab",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D017322",
      "descriptor_name": "Clinical Trials, Phase II as Topic",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D004305",
      "descriptor_name": "Dose-Response Relationship, Drug",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D023381",
      "descriptor_name": "Endpoint Determination",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D066246",
      "descriptor_name": "ErbB Receptors",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D000069347",
      "descriptor_name": "Erlotinib Hydrochloride",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D005076",
      "descriptor_name": "Exanthema",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D005260",
      "descriptor_name": "Female",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D000077156",
      "descriptor_name": "Gefitinib",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D006258",
      "descriptor_name": "Head and Neck Neoplasms",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D006801",
      "descriptor_name": "Humans",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D008175",
      "descriptor_name": "Lung Neoplasms",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D010051",
      "descriptor_name": "Ovarian Neoplasms",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D011799",
      "descriptor_name": "Quinazolines",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D011799",
      "descriptor_name": "Quinazolines",
      "qualifier_ui": "Q000494",
      "qualifier_name": "pharmacology",
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D011799",
      "descriptor_name": "Quinazolines",
      "qualifier_ui": "Q000627",
      "qualifier_name": "therapeutic use",
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D012720",
      "descriptor_name": "Severity of Illness Index",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D016019",
      "descriptor_name": "Survival Analysis",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D016896",
      "descriptor_name": "Treatment Outcome",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    }
  ],
  "locations_count": 1,
  "locations": [
    {
      "is_oa": false,
      "landing_page_url": "https://pubmed.ncbi.nlm.nih.gov/14682120",
      "pdf_url": null,
      "source": {
        "id": "https://openalex.org/S4306525036",
        "display_name": "PubMed",
        "issn_l": null,
        "issn": null,
        "is_oa": false,
        "is_in_doaj": false,
        "is_indexed_in_scopus": false,
        "is_core": false,
        "host_organization": "https://openalex.org/I1299303238",
        "host_organization_name": "National Institutes of Health",
        "host_organization_lineage": [
          "https://openalex.org/I1299303238"
        ],
        "host_organization_lineage_names": [
          "National Institutes of Health"
        ],
        "type": "repository"
      },
      "license": null,
      "license_id": null,
      "version": null,
      "is_accepted": false,
      "is_published": false
    }
  ],
  "best_oa_location": null,
  "sustainable_development_goals": [
    {
      "score": 0.86,
      "id": "https://metadata.un.org/sdg/3",
      "display_name": "Good health and well-being"
    }
  ],
  "grants": [],
  "datasets": [],
  "versions": [],
  "referenced_works_count": 0,
  "referenced_works": [],
  "related_works": [
    "https://openalex.org/W2979585789",
    "https://openalex.org/W2940909520",
    "https://openalex.org/W2266347788",
    "https://openalex.org/W2224970622",
    "https://openalex.org/W2186047679",
    "https://openalex.org/W2184487997",
    "https://openalex.org/W2135772797",
    "https://openalex.org/W2120200191",
    "https://openalex.org/W2015874289",
    "https://openalex.org/W1997605441"
  ],
  "abstract_inverted_index": {
    "Rash": [
      0,
      62
    ],
    "is": [
      1,
      218,
      250
    ],
    "a": [
      2,
      20,
      52,
      192
    ],
    "class": [
      3
    ],
    "effect": [
      4
    ],
    "of": [
      5,
      26,
      33,
      37,
      181,
      194,
      236,
      245
    ],
    "HER1/epidermal": [
      6
    ],
    "growth": [
      7
    ],
    "factor": [
      8
    ],
    "receptor": [
      9
    ],
    "(EGFR)-targeted": [
      10
    ],
    "agents,": [
      11
    ],
    "and": [
      12,
      18,
      45,
      48,
      58,
      101,
      121,
      124,
      151,
      171,
      199,
      223,
      231,
      243
    ],
    "has": [
      13
    ],
    "occurred": [
      14
    ],
    "with": [
      15,
      68,
      72,
      82,
      89,
      94,
      106,
      132,
      139,
      144,
      156,
      168,
      175,
      184,
      220,
      247
    ],
    "high": [
      16
    ],
    "frequency": [
      17
    ],
    "in": [
      19,
      23,
      29,
      40,
      70,
      80,
      92,
      104,
      130,
      142,
      154,
      172
    ],
    "dose-dependent": [
      21
    ],
    "manner": [
      22
    ],
    "clinical": [
      24
    ],
    "trials": [
      25,
      36
    ],
    "these": [
      27
    ],
    "agents": [
      28,
      249
    ],
    "cancer": [
      30,
      50,
      75,
      126
    ],
    "patients.": [
      31
    ],
    "Analysis": [
      32
    ],
    "phase": [
      34
    ],
    "II": [
      35
    ],
    "erlotinib": [
      38,
      197,
      211
    ],
    "(Tarceva)": [
      39
    ],
    "non-small-cell": [
      41,
      73,
      117
    ],
    "lung": [
      42,
      74,
      118
    ],
    "cancer,": [
      43,
      47,
      119,
      123
    ],
    "head": [
      44,
      120
    ],
    "neck": [
      46,
      122
    ],
    "ovarian": [
      49,
      125
    ],
    "shows": [
      51
    ],
    "significant": [
      53
    ],
    "association": [
      54,
      180,
      240
    ],
    "between": [
      55,
      241
    ],
    "rash": [
      56,
      84,
      97,
      109,
      134,
      147,
      159,
      182,
      188,
      242
    ],
    "severity": [
      57,
      63,
      183
    ],
    "objective": [
      59
    ],
    "tumor": [
      60
    ],
    "response.": [
      61,
      209
    ],
    "was": [
      64,
      85,
      135
    ],
    "highly": [
      65
    ],
    "significantly": [
      66
    ],
    "associated": [
      67,
      219
    ],
    "survival": [
      69,
      79,
      129,
      232
    ],
    "patients": [
      71,
      81,
      131
    ],
    "receiving": [
      76
    ],
    "erlotinib;": [
      77
    ],
    "median": [
      78,
      128
    ],
    "no": [
      83,
      133
    ],
    "46.5": [
      86
    ],
    "days,": [
      87,
      137
    ],
    "compared": [
      88,
      138
    ],
    "257": [
      90
    ],
    "days": [
      91,
      103,
      141,
      153
    ],
    "those": [
      93,
      105,
      143,
      155
    ],
    "grade": [
      95,
      107,
      145,
      157
    ],
    "1": [
      96,
      146
    ],
    "(P": [
      98,
      110,
      148,
      160
    ],
    "<": [
      99,
      111
    ],
    ".0001)": [
      100,
      150
    ],
    "597": [
      102
    ],
    "2/3": [
      108
    ],
    ".0001).": [
      112,
      162
    ],
    "Similarly,": [
      113
    ],
    "for": [
      114
    ],
    "the": [
      115,
      213,
      237
    ],
    "combined": [
      116
    ],
    "studies,": [
      127
    ],
    "103": [
      136
    ],
    "191": [
      140
    ],
    "=": [
      149,
      161
    ],
    "266": [
      152
    ],
    "2/3/4": [
      158
    ],
    "Similar": [
      163
    ],
    "findings": [
      164
    ],
    "have": [
      165
    ],
    "been": [
      166
    ],
    "made": [
      167
    ],
    "cetuximab": [
      169
    ],
    "(Erbitux)": [
      170
    ],
    "some": [
      173
    ],
    "settings": [
      174
    ],
    "gefitinib": [
      176
    ],
    "(Iressa).": [
      177
    ],
    "The": [
      178
    ],
    "strong": [
      179
    ],
    "response/survival": [
      185
    ],
    "suggests": [
      186
    ],
    "that": [
      187
    ],
    "may": [
      189,
      200,
      227
    ],
    "serve": [
      190
    ],
    "as": [
      191
    ],
    "marker": [
      193
    ],
    "response": [
      195,
      229
    ],
    "to": [
      196,
      203,
      206
    ],
    "treatment": [
      198,
      205,
      246
    ],
    "be": [
      201
    ],
    "used": [
      202
    ],
    "guide": [
      204
    ],
    "obtain": [
      207
    ],
    "optimal": [
      208
    ],
    "Dosing": [
      210
    ],
    "at": [
      212
    ],
    "maximum": [
      214
    ],
    "tolerated": [
      215
    ],
    "dose,": [
      216
    ],
    "which": [
      217
    ],
    "more": [
      221,
      224
    ],
    "frequent": [
      222
    ],
    "severe": [
      225
    ],
    "rash,": [
      226
    ],
    "improve": [
      228
    ],
    "rates": [
      230
    ],
    "durations.": [
      233
    ],
    "Further": [
      234
    ],
    "study": [
      235
    ],
    "potentially": [
      238
    ],
    "important": [
      239
    ],
    "outcome": [
      244
    ],
    "EGFR-targeted": [
      248
    ],
    "needed.": [
      251
    ]
  },
  "abstract_inverted_index_v3": null,
  "cited_by_api_url": "https://api.openalex.org/works?filter=cites:W2405151655",
  "counts_by_year": [
    {
      "year": 2024,
      "cited_by_count": 1
    },
    {
      "year": 2023,
      "cited_by_count": 4
    },
    {
      "year": 2020,
      "cited_by_count": 2
    },
    {
      "year": 2019,
      "cited_by_count": 1
    },
    {
      "year": 2018,
      "cited_by_count": 2
    },
    {
      "year": 2017,
      "cited_by_count": 1
    },
    {
      "year": 2016,
      "cited_by_count": 3
    },
    {
      "year": 2015,
      "cited_by_count": 10
    },
    {
      "year": 2014,
      "cited_by_count": 8
    },
    {
      "year": 2013,
      "cited_by_count": 7
    },
    {
      "year": 2012,
      "cited_by_count": 7
    }
  ],
  "updated_date": "2025-06-16T19:45:54.882249",
  "created_date": "2016-06-24"
}